Prospective Longitudinal Monocentric Study to Measure Limb Movement in Patients With FGFR3-related Skeletal Dysplasia

Recruiting now

Conditions studied: Achondroplasia, Hypochondroplasia

In brief

The study aims to identify which Syde®-derived digital outcomes are reliable in FGFR3-related Skeletal Dysplasia. This requires to set-up a natural history study to measure limb movements in patients with ACH or HCH.

Key facts

Study ID

NCT07388966

Run by

SYSNAV

People needed

40

Starts

2026-02-06

Expected to finish

2028-02-01

Last updated by the study team

2026-02-20

Who can join

Age: 3 and older, up to 65. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Aged 3 years old or older at the time of consent.
• Written informed consent obtained:
• From the parent(s) or legal guardian(s) for participants under 18 years old.
• From participants 18 years old and older.
• Affiliated to, or beneficiary of a social security category
• Able to walk unassisted for at least 10 meters.
• Genetically confirmed diagnosis with one pathogenic variant (ACMG class IV \& V) of achondroplasia or hypochondroplasia.
• Participant (and caregivers for participants under 18 years old) willing and able to comply with all study procedures including: questionnaires, Syde® related procedures

You may not qualify if…

• Subjects who have short stature condition other than ACH/HCH.
• Presence of cognitive disorders that limit their understanding of the data collection process (training of device use and 4-week recording periods every 6 months, device return at the end of the study), the implication of the study and consent.
• Presence or history of any concurrent disease or condition that could interfere with study participation, impact pediatric growth, affect motor or balance or gait function (such as neurological, endocrine, infectious, allergic, osteoarthritis, or inflammatory), assessed by the investigator.
• Females who are pregnant, or planning to become pregnant during the study duration.
• Body Mass Index = 35 kg/m2.
• Recent upper and/or lower limbs injury (trauma/fracture or surgery) in the 6 months preceding inclusion.
• Prior limb lengthening surgery or planned or expected to have limb lengthening surgery while enrolled in the study.
• Presence of guided growth hardware (such as 8-plates) or planned orthopedic surgeries during the study.
• Vulnerable patient (guardianship, curatorship or safeguarding of justice), unable to provide informed consent or who is unable to express their consent.

Where it is running

• Hopital Necker — Paris, France (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.